BusinessBioStem Technologies Inc. Announces a Pre-Clinical Study of BSEM17-115 at University of MiamiBy Nasdaq OMXDec 11, 2017, 2:43 PM UTC
BusinessBioStem Technologies, Inc. Files “Issuer Company-Related Action Notification” with the Financial Industry Regulatory Authority, Requesting Name and Symbol Change to BioBlue TechnologiesBy Nasdaq OMXNov 1, 2017, 4:26 PM UTC